Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel
- PMID: 19549232
- DOI: 10.1111/j.1365-2230.2009.03355.x
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel
Abstract
Primary erythermalgia (erythromelalgia) is a rare autosomal dominant condition characterized by intermittent attacks of erythema, increased skin temperature and severe burning pain in the extremities, in a bilateral symmetrical distribution. Mutations in the SCN9A gene, which encodes a voltage-gated sodium channel have been shown to cause this disease. We report a family identified to have a mutation in the SCN9A gene, in which one severely affected family member has responded to the therapeutic combination of gabapentin and carbamazepine treatment.
Similar articles
-
Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations.Klin Padiatr. 2012 Sep;224(5):309-12. doi: 10.1055/s-0031-1287823. Epub 2011 Dec 14. Klin Padiatr. 2012. PMID: 22170168
-
[From gene to disease; primary erythermalgia--a neuropathic disease as a consequence of mutations in a sodium pump gene].Ned Tijdschr Geneeskd. 2006 Jan 28;150(4):194-6. Ned Tijdschr Geneeskd. 2006. PMID: 16471234 Review. Dutch.
-
SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels.J Invest Dermatol. 2005 Jun;124(6):1333-8. doi: 10.1111/j.0022-202X.2005.23737.x. J Invest Dermatol. 2005. PMID: 15955112
-
Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia.J Med Genet. 2004 Mar;41(3):171-4. doi: 10.1136/jmg.2003.012153. J Med Genet. 2004. PMID: 14985375 Free PMC article.
-
Severe case and literature review of primary erythromelalgia: novel SCN9A gene mutation.Vasc Med. 2012 Feb;17(1):44-9. doi: 10.1177/1358863X11422584. Epub 2011 Oct 27. Vasc Med. 2012. PMID: 22033523 Review.
Cited by
-
Primary erythromelalgia mainly manifested by hypertensive crisis: A case report and literature review.Front Pediatr. 2022 Aug 16;10:796149. doi: 10.3389/fped.2022.796149. eCollection 2022. Front Pediatr. 2022. PMID: 36052366 Free PMC article. Review.
-
[Neuropathic pain associated with Nav1.7 mutations: clinical picture and treatment].Nervenarzt. 2013 Dec;84(12):1428-35. doi: 10.1007/s00115-012-3621-7. Nervenarzt. 2013. PMID: 24202110 Review. German.
-
Erythromelalgia: a cutaneous manifestation of neuropathy?An Bras Dermatol. 2018 Jan-Feb;93(1):86-94. doi: 10.1590/abd1806-4841.20187535. An Bras Dermatol. 2018. PMID: 29641704 Free PMC article. Review.
-
Erythromelalgia in an Adolescent Female.Mediterr J Rheumatol. 2022 Jun 30;33(2):256-258. doi: 10.31138/mjr.33.2.256. eCollection 2022 Jun. Mediterr J Rheumatol. 2022. PMID: 36128208 Free PMC article.
-
Sodium channelopathies and pain.Pflugers Arch. 2010 Jul;460(2):249-63. doi: 10.1007/s00424-009-0779-3. Epub 2010 Jan 26. Pflugers Arch. 2010. PMID: 20101409 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources